Friday, 23 Aug 2019

You are here

Top Rheumatology Centers Led by Johns Hopkins

Medscape has reported the results of the US News & World Report's annual ranking of the best adult rheumatology hospitals nationwide has again honored Johns Hopkins Hospital, with runner up status going to the Cleveland Clinic, Hospital for Special Surgery, NewYork-Presbyterian University of Columbia, and Cornell. 

These results are based on surveys of US rheumatology specialists responding to US News surveys.

Johns Hopkins was named by 42.2% of rheumatology specialists as being the best rheumtology center, just bating out the Cleveland Clinic (41.3%) and the Hospital for Special Surgery (34.7%)

The 2019 Top 14 Ranking of US rheumatology hospitals: 

  1. Johns Hopkins (42.2%)
  2. Cleveland Clinic (41.3%)
  3. Hospital for Special Surgery (34.7%)
  4. Mayo Clinic, Rochester, Minnesota (30.4%)
  5. Brigham and Women's Hospital, Boston, Massachusetts (21.4%)
  6. Massachusetts General Hospital, Boston (15.6%)
  7. UCSF Medical Center, San Francisco (15.1%)
  8. NYU Langone Hospitals, New York City (12.3%)
  9. UCLA Medical Center, Los Angeles (11.6%)
  10. University of Alabama at Birmingham Hospital (9.2%)
  11. Duke University Hospital, Durham, North Carolina (5.9%)
  12. University of Michigan Hospitals-Michigan Medicine, Ann Arbor (5.6%)
  13. MUSC Health-University Medical Center, Charleston, South Carolina (5.5%)
  14. Northwestern Memorial Hospital, Chicago, Illinois (5.0%)
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

A Multidimensional Definition of Remission

A study from Leeds suggests 'multi-dimensional remission' (MDR) can be seen in one-third of RA patients achieving DAS28-remission; such patients have better patient-reported outcome measures, making it an optimal goal, especially from a patient's perspective.

Good Pregnancy Outcomes for DMARD Exposed JIA Patients

A study of pregnancy outcomes in 98 women with juvenile idiopathic arthritis (JIA) who were exposed to DMARDs shows no increased risk of major adverse pregnancy outcomes.

A total of 152 pregnancies in 98 women with JIA and 39 pregnancies involving 21 male patients as partners were reviewed. The majority had a polyarticular JIA (61%). The average age at first pregnancy was 24.1 years, and their mean disease duration was 13.8 years.

Autoantibodies Don't Disappear With Remission in RA

Immunologic remission in rheumatoid arthritis, defined as the disappearance of anti-citrullinated protein antibodies and rheumatoid factor, was seen infrequently among patients achieving sustained clinical remission and did not correlate with the disappearance of symptoms, a long-term Dutch study found.

Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease

Serologic testing is the principal means of laboratory diagnosis of Lyme disease. Current recommendations include using a sensitive enzyme immunoassay (EIA) or immunofluorescence assay, followed by a western immunoblot assay for specimens yielding positive or equivocal results. On July 29, 2019, the Food and Drug Administration cleared several Lyme disease serologic assays with new indications for use, allowing for an EIA rather than western immunoblot assay as the second test in a Lyme disease testing algorithm. Thus, serologic assays that utilize a second EIA in place of western immunoblot assay are acceptable alternatives for the serologic diagnosis of Lyme disease.

Trends in Inflammatory Arthritis Care in Germany

The German National Database (NDB) has reviewed their experience in the care and quality of life of inflammatory rheumatic disease patients snce 1993, showing improved use of metrics, improved outcomes and a changing profile of biologic and anti-rheumatic drug use.